I just taught the Theranos case in my course on “Innovation and Industry Development,” co-taught with Prof. Elizabeth Lyons. The first half is about positioning a startup: powerful new technology, established incumbents, how should we enter to disrupt the industry and make the world a better place? Any moderate set of numbers makes Theranos’ reputed $9,000,000,000 valuation look reasonable.
The “case” presently consists of four articles. I put together a set of overhead slides to generate and lead the discussion. The first half ends with some general lessons about disruptive innovation and whether to follow an open or closed IP strategy. The second half starts in December 2015 and discusses the crash. I also compare Theranos with the Google contact lens (another technically impossible pseudo-invention).
There are lots of technology-policy-related stories this weekend. The first three concern about excess market power in tech markets, and its effects. The remaining three are miscellaneous subjects at the intersection of technology, policy, and politics.
Suggestion: If a newspaper is refusing to let you read an article, you can often get it by searching for it (on Google – irony alert, see one of the stories below), and visiting from the search result.
And a humble brag: Only the last of these stories directly concerns He Who Must Not Be Named. Nor did I mention Juicero, whose idiocy I tweeted about when it first came to market.
Is It Time to Break Up Google?
In just 10 years, the world’s five largest companies by market capitalization have all changed, save for one: Microsoft. Exxon Mobil, General Electric, Citigroup and Shell Oil are out and Apple, Alphabet (the parent company of Google), Amazon and Facebook have taken their place.
They’re all tech companies, and each dominates its corner of the industry: Google has an 88 percent market share in search advertising, Facebook (and its subsidiaries Instagram, WhatsApp and Messenger) owns 77 percent of mobile social traffic and Amazon has a 74 percent share in the e-book market. In classic economic terms, all three are monopolies.
Joe Stiglitz critique of TPP Trans-Pacific Partnership treaty:
Corporations on both sides of the Pacific have an interest at lowering regulatory standards—to protect the environment, to protect consumers, to protect workers, to protect health. But ordinary citizens, our society, will suffer. So you can get corporations on both sides pushing an agenda that will be increasing corporate profits at the cost of the well-being of people on both sides of the Pacific.
…Philip Morris is suing Uruguay under an investment agreement. It says, “This interferes with our basic right to sell products to kill people.” It’s like the Opium War 150 years ago, where the West went to war because China said, “We don’t want opium,” and we said, “That interferes with the basic right to trade.”